Skip to main content
Top
Published in: Supportive Care in Cancer 5/2017

Open Access 01-05-2017 | Letter to the editor

Importance of eliminating potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy

Authors: Yasuyuki Shimada, Yumiko Nakagawa, Kazuki Ide, Izumi Sato, Shotaro Hagiwara, Hiroshi Yamada, Yohei Kawasaki, Yutaka Maruoka

Published in: Supportive Care in Cancer | Issue 5/2017

Login to get access

Excerpt

Letter to the Editor, …
Literature
1.
go back to reference Raut A, Huryn JM, Hwang FR, Zlotolow IM (2001) Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome. Oral Surg Oral Med Oral Pathol Oral Radio Endod 92:49–55. doi:10.1067/moe.2001.113588 CrossRef Raut A, Huryn JM, Hwang FR, Zlotolow IM (2001) Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome. Oral Surg Oral Med Oral Pathol Oral Radio Endod 92:49–55. doi:10.​1067/​moe.​2001.​113588 CrossRef
2.
go back to reference Akashi M, Shibuya Y, Kusumoto J et al (2013) Myelosuppression grading of chemotherapies for hematologic malignancies to facilitate communication between medical and dental staff: lessons from two cases experienced odontogenic septicemia. BMC Oral Health 13:41. doi:10.1186/1472-6831-13-41 CrossRefPubMedPubMedCentral Akashi M, Shibuya Y, Kusumoto J et al (2013) Myelosuppression grading of chemotherapies for hematologic malignancies to facilitate communication between medical and dental staff: lessons from two cases experienced odontogenic septicemia. BMC Oral Health 13:41. doi:10.​1186/​1472-6831-13-41 CrossRefPubMedPubMedCentral
6.
go back to reference Brickley M, Armstrong R, Shepherd J, Kay E (1995) The relevance of health state utilities to lower third molar surgery. Int Dent J 45:124–128PubMed Brickley M, Armstrong R, Shepherd J, Kay E (1995) The relevance of health state utilities to lower third molar surgery. Int Dent J 45:124–128PubMed
7.
go back to reference Kojima A, Ekuni D, Mizutani S et al (2013) Relationships between self-rated oral health, subjective symptoms, oral health behavior and clinical conditions in Japanese university students: a cross-sectional survey at Okayama University. BMC Oral Health 13:62. doi:10.1186/1472-6831-13-62 CrossRefPubMedPubMedCentral Kojima A, Ekuni D, Mizutani S et al (2013) Relationships between self-rated oral health, subjective symptoms, oral health behavior and clinical conditions in Japanese university students: a cross-sectional survey at Okayama University. BMC Oral Health 13:62. doi:10.​1186/​1472-6831-13-62 CrossRefPubMedPubMedCentral
9.
go back to reference Williford SK, Salisbury PL 3rd, Peacock JE Jr, Cruz JM, Powell BL, Lyerly ES, Capizzi RL (1989) The safety of dental extractions in patients with hematologic malignancies. J Clin Oncol 7:798–802CrossRefPubMed Williford SK, Salisbury PL 3rd, Peacock JE Jr, Cruz JM, Powell BL, Lyerly ES, Capizzi RL (1989) The safety of dental extractions in patients with hematologic malignancies. J Clin Oncol 7:798–802CrossRefPubMed
10.
go back to reference Haytac MC, Dogan MC, Antmen B (2004) The results of a preventive dental program for pediatric patients with hematologic malignancies. Oral Health Prev Dent 2:59–65PubMed Haytac MC, Dogan MC, Antmen B (2004) The results of a preventive dental program for pediatric patients with hematologic malignancies. Oral Health Prev Dent 2:59–65PubMed
Metadata
Title
Importance of eliminating potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy
Authors
Yasuyuki Shimada
Yumiko Nakagawa
Kazuki Ide
Izumi Sato
Shotaro Hagiwara
Hiroshi Yamada
Yohei Kawasaki
Yutaka Maruoka
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3643-6

Other articles of this Issue 5/2017

Supportive Care in Cancer 5/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine